Greater Cannabis Company (GCAN) Debt to Equity (2017 - 2022)
Greater Cannabis Company's Debt to Equity history spans 6 years, with the latest figure at -$0.46 for Q3 2022.
- For Q3 2022, Debt to Equity rose 51.42% year-over-year to -$0.46; the TTM value through Sep 2022 reached -$0.46, up 51.42%, while the annual FY2021 figure was -$0.55, 40.35% up from the prior year.
- Debt to Equity reached -$0.46 in Q3 2022 per GCAN's latest filing, down from -$0.41 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $3.3 in Q1 2018 to a low of -$3.01 in Q2 2021.
- Average Debt to Equity over 5 years is -$0.27, with a median of -$0.46 recorded in 2022.
- Peak YoY movement for Debt to Equity: tumbled 5564.81% in 2018, then skyrocketed 86.53% in 2022.
- A 5-year view of Debt to Equity shows it stood at -$0.46 in 2018, then skyrocketed by 63.55% to -$0.17 in 2019, then crashed by 452.79% to -$0.93 in 2020, then surged by 40.35% to -$0.55 in 2021, then increased by 16.45% to -$0.46 in 2022.
- Per Business Quant, the three most recent readings for GCAN's Debt to Equity are -$0.46 (Q3 2022), -$0.41 (Q2 2022), and -$0.42 (Q1 2022).